Novel Approaches to the Development of Antimigraine Drugs: A Focus on 5-HT2A Receptor Antagonists
Crossref DOI link: https://doi.org/10.1134/S1068162019020146
Published Online: 2019-06-05
Published Print: 2019-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Spasov, A. A.
Yakovlev, D. S.
Brigadirova, A. A.
Maltsev, D. V.
Agatsarskaya, Y. V.
Text and Data Mining valid from 2019-03-01
Version of Record valid from 2019-03-01
Article History
Received: 3 April 2018
Revised: 5 May 2018
Accepted: 2 August 2018
First Online: 5 June 2019